sciencenewsnet.in

World’s Largest Specialty Clinical Data Registry Reveals Insights into Eye Disease Prevention and Treatment

SAN FRANCISCO – Nov. 13, 2020 – The IRIS® Registry powered a number of big data studies this year, many of which will be presented at AAO 2020 Virtual, the 124th annual meeting of the American Academy of Ophthalmology. The research findings are now available to view on demand. 

“With a growing pool of aggregated data, the IRIS Registry empowers ophthalmologists to recognize disease patterns, better define risk factors, and improve prevention and treatment options for their patients,” said Flora Lum, MD, vice president of Quality and Data Science at the American Academy of Ophthalmology. “All IRIS Registry studies being presented at AAO 2020 this year reveal interesting and promising results for a better future in eye care.” 

Launched in 2014, the IRIS Registry is the nation’s first comprehensive eye disease registry. It currently includes data from nearly 60 million unique patients and 350 million patient visits.

IRIS Registry-powered research presented at AAO 2020 Virtual:

Papers and Posters

Subspecialty Day Presentations

Symposium

Scientific Findings From Big Data From the RPB/AAO Award for IRIS Registry Research Four awardees discuss their studies. Sym43, Chair: Michael F. Chiang. Available on demand

 

To learn more about the IRIS Registry, visit: www.aao.org/iris-registry

 

About the American Academy of Ophthalmology The American Academy of Ophthalmology is the world’s largest association of eye physicians and surgeons. A global community of 32,000 medical doctors, we protect sight and empower lives by setting the standards for ophthalmic education and advocating for our patients and the public. We innovate to advance our profession and to ensure the delivery of the highest-quality eye care. Our EyeSmart® program provides the public with the most trusted information about eye health. For more information, visit aao.org.